Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 2 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Jan. 2, 2025 OCGN A 1,145,468 · · 1,145,468 Direct · Acquired (price as of 2026-10-02)
April 16, 2024 OCGN A 308,465 · · 308,465 Direct · Acquired (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Jan. 2, 2025 OCGN Option (Right to Buy) Common Stock (1,145,468) $0.90 Jan. 2, 2035 1,145,468 Acquired
April 16, 2024 OCGN Option (Right to Buy) Common Stock (308,465) $1.59 April 16, 2034 308,465 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
March 20, 2024 OCGN Common Stock 1,643 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

OCGN

M.D., MPH, CMI (7) Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $448,050 $190,130 $1,375,478 $868,975 · · $5,847 $2,888,481
2024 $344,375 $258,362 $709,003 $413,961 · · · $1,725,700

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.